Xymogen Reviews
Summary
Xymogen is a supplement company with 278 products, including 5-HTP, 5-MTHF, ALAmax Protect and ATP Ignite. RiskScore has not tested its products yet. The FDA has received 29 adverse event reports submitted to the FDA covering 2011 to 2025, and 1 recall from 2013, which was issued because a product was labeled as a medical food rather than a dietary supplement.
Public safety signals
1 recall and 29 adverse event reports in public records.
- Adverse eventSource: openFDA
Adverse event report: Renal failure
Product: XYMOGEN ACTIVNUTRIENTS; XYMOGEN MEDCAPS IS. Outcome: Other Serious or Important Medical Event. Reactions: Renal failure. FDA CAERS report 2025-CFS-018303.
- Adverse eventSource: openFDA
Adverse event report: Dehydration, Hospitalisation, Malnutrition
Product: XYMOGEN OPTIMAG NEURO. Outcome: Other Serious or Important Medical Event. Reactions: Dehydration, Hospitalisation, Malnutrition. FDA CAERS report 2025-CFS-015469.
- Adverse eventSource: openFDA
Adverse event report: Abdominal distension, Asthenia, Blood potassium decreased and 4 more
Product: XYMOGEN BERBERINE ES-5. Outcome: Life Threatening, Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Abdominal distension, Asthenia, Blood potassium decreased, Dehydration, Fall, Sensory disturbance, Urinary incontinence. FDA CAERS report 2024-CFS-009350.
- Adverse eventSource: openFDA
Adverse event report: Abdominal pain, Blood pressure increased
Product: XYMOGEN OPTICLEANSE GHI VANILLA DELIGHT SUGAR AND STEVIA FREE SINGLE SERVING PACKETS. Outcome: Other Serious or Important Medical Event. Reactions: Abdominal pain, Blood pressure increased. FDA CAERS report 2024-CFS-005367.
- Adverse eventSource: openFDA
Adverse event report: Anaphylactic reaction
Product: XYMOGEN K2-D3; XYMOGEN S-ACETYL GLUTATHIONE EP; XYMOGEN OPTIFIBER LEAN; XYMOGEN OMEGA MONOPURE; XYMOGEN MONOPURE 1300 EC; XYMOGEN METHYL PROTECT; XYMOGEN COQMAX UBIQUINOL. Outcome: Life Threatening, Other Serious or Important Medical Event, Allergic Reaction. Reactions: Anaphylactic reaction. FDA CAERS report 2024-CFS-002709.
- Adverse eventSource: openFDA
Adverse event report: Blood glucose increased, Blood pressure increased, Blood thyroid stimulating hormone increased and 3 more
Product: XYMOGEN ACTIVNUTRIENTS WITHOUT IRON; XYMOGEN OSSOPAN 1100 WITH D3 AND K2; XYMOGEN OPTIFIBER LEAN; XYMOGEN LIVER PROTECT; XYMOGEN LIPOTROPIX; XYMOGEN DIMENSION 3; XYMOGEN CINNDROMEX; XYMOGEN BERBERINE. Outcome: Hospitalization, Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Blood glucose increased, Blood pressure increased, Blood thyroid stimulating hormone increased, Deafness, Heart rate increased, Tinnitus. FDA CAERS report 2023-CFS-010289.
- Adverse eventSource: openFDA
Adverse event report: Atrial fibrillation
Product: XYMOGEN T-150. Outcome: Other Serious or Important Medical Event. Reactions: Atrial fibrillation. FDA CAERS report 2023-CFS-005306.
- Adverse eventSource: openFDA
Adverse event report: Acute kidney injury
Product: XYMOGEN CORTISOLV; XYMOGEN RELAXMAX; XYMOGEN OMEGA MONOPURE; XYMOGEN MEDCAPS T3; XYMOGEN FEMQUI; XYMOGEN DHEA; XYMOGEN D3 LIQUID. Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider. Reactions: Acute kidney injury. FDA CAERS report 2022-CFS-015974.
- Adverse eventSource: openFDA
Adverse event report: Agitation, Anxiety, Asthenia and 10 more
Product: XYMOGEN METHYL PROTECT. Outcome: Other Serious or Important Medical Event. Reactions: Agitation, Anxiety, Asthenia, Constipation, Dehydration, Electrocardiogram abnormal, Insomnia, Myalgia, Palpitations, Panic attack, Restless legs syndrome, Syncope, Weight decreased. FDA CAERS report 2021-CFS-010350.
- Adverse eventSource: openFDA
Adverse event report: Dizziness, Dyspnoea, Hyperhidrosis and 1 more
Product: XYMOGEN ADRENAL ESSENCE; XYMOGEN RESVERATIN PLUS; XYMOGEN MAGNESIUM CITRATE; XYMOGEN B ACTIV. Outcome: Other Serious or Important Medical Event. Reactions: Dizziness, Dyspnoea, Hyperhidrosis, Loss of consciousness. FDA CAERS report 2021-CFS-006668.
Show 20 more
- Adverse eventSource: openFDA
Adverse event report: Lymphadenopathy
Product: XYMOGEN COQMAX UBIQUINOL. Outcome: Disability, Visited a Health Care Provider. Reactions: Lymphadenopathy. FDA CAERS report 2021-CFS-001717.
- Adverse eventSource: openFDA
Adverse event report: Hepatic enzyme increased, Hepatic pain, Nausea
Product: XYMOGEN OPTICLEANSE GHI VANILLA DELIGHT. Outcome: Hospitalization. Reactions: Hepatic enzyme increased, Hepatic pain, Nausea. FDA CAERS report 2020-CFS-011152.
- Adverse eventSource: openFDA
Adverse event report: Diarrhoea, Dyspnoea, Hyperhidrosis and 4 more
Product: XYMOGEN OPTICLEANSE GHI VANILLA DELIGHT. Outcome: Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Diarrhoea, Dyspnoea, Hyperhidrosis, Hypersensitivity, Nausea, Urticaria, Wheezing. FDA CAERS report 2020-CFS-005069.
- Adverse eventSource: openFDA
Adverse event report: Choking, Cough, Dyspnoea and 6 more
Product: XYMOGEN OPTICLEANSE GHI CREAMY CHOCOLATE (SSP). Outcome: Other Serious or Important Medical Event. Reactions: Choking, Cough, Dyspnoea, Muscle spasms, Nausea, Retching, Rhinorrhoea, Tremor, Wheezing. FDA CAERS report 2020-CFS-004905.
- Adverse eventSource: openFDA
Adverse event report: Panic attack
Product: XYMOGEN ADRENALIV. Outcome: Hospitalization, Other Serious or Important Medical Event. Reactions: Panic attack. FDA CAERS report 2020-CFS-004426.
- Adverse eventSource: openFDA
Adverse event report: Anaphylactic reaction, Pruritus, Rash and 1 more
Product: XYMOGEN MOOD FOOD. Outcome: Life Threatening, Other Serious or Important Medical Event. Reactions: Anaphylactic reaction, Pruritus, Rash, Swollen tongue. FDA CAERS report 2019-CFS-006998.
- Adverse eventSource: openFDA
Adverse event report: Abdominal distension, Constipation, Flatulence and 2 more
Product: XYMOGEN B ACTIV; XYMOGEN XENO PROT X; XYMOGEN PROBIOMAX PLUS DF; XYMOGEN OPTICLEANSE GHI; XYMOGEN OMEGA MONO PURE; XYMOGEN METHYL PROTECT; XYMOGEN LIPTROPIX; XYMOGEN IGG 2000 CWP POWDER; XYMOGEN IG 26 PLUS POWDER; XYMOGEN FIT FOOD LEAN COMPLETE. Outcome: Other Serious or Important Medical Event. Reactions: Abdominal distension, Constipation, Flatulence, Hepatic enzyme increased, Nausea. FDA CAERS report 2019-CFS-001550.
- Adverse eventSource: openFDA
Adverse event report: Blood magnesium abnormal, Fall, Head injury and 4 more
Product: XYMOGEN ATP IGNITE MIXED BERRY. Outcome: Other Serious or Important Medical Event, Visited Emergency Room, Visited a Health Care Provider. Reactions: Blood magnesium abnormal, Fall, Head injury, Heart rate increased, Laceration, Loss of consciousness, Oxygen consumption decreased. FDA CAERS report 2018-CFS-010752.
- Adverse eventSource: openFDA
Adverse event report: Blood cholesterol increased, Convulsion, Dizziness and 2 more
Product: XYMOGEN OSAPLEX MK-7 (EP). Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider. Reactions: Blood cholesterol increased, Convulsion, Dizziness, Euphoric mood, Headache. FDA CAERS report 2018-CFS-004634.
- Adverse eventSource: openFDA
Adverse event report: Hypersensitivity, Lip swelling, Pruritus and 3 more
Product: XYMOGEN HORMONE PROTECT. Outcome: Other Outcome. Reactions: Hypersensitivity, Lip swelling, Pruritus, Swelling, Swelling face, Urticaria. FDA CAERS report 202781.
- Adverse eventSource: openFDA
Adverse event report: Arthralgia, Eosinophilia myalgia syndrome, Gait disturbance and 4 more
Product: XYMOGEN 5-HTP CR. Outcome: Disability, Visited a Health Care Provider. Reactions: Arthralgia, Eosinophilia myalgia syndrome, Gait disturbance, Joint stiffness, Muscle fatigue, Musculoskeletal stiffness, Myalgia. FDA CAERS report 177039.
- Adverse eventSource: openFDA
Adverse event report: Arrhythmia, Cardiac flutter, Palpitations
Product: XYMOGEN OPTICLEANSE GHI CHAI. Outcome: Visited a Health Care Provider. Reactions: Arrhythmia, Cardiac flutter, Palpitations. FDA CAERS report 174552.
- Adverse eventSource: openFDA
Adverse event report: Convulsion
Product: XYMOGEN CHELEX 120C. Outcome: Hospitalization, Visited a Health Care Provider. Reactions: Convulsion. FDA CAERS report 173246.
- Adverse eventSource: openFDA
Adverse event report: Chest pain, Mitral valve prolapse, Palpitations
Product: XYMOGEN METHYL PROTECT 60C. Outcome: Other Outcome. Reactions: Chest pain, Mitral valve prolapse, Palpitations. FDA CAERS report 171097.
- RecallSource: openFDA
Class III recall: Product was labeled as a medical food as opposed to a dietary supplement.
XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food Distributed by Xymogen Orlando, Florida. Also sold and distributed under various brands and firms: *1. 4XLipidComplete (Omega-3 Phospholipid 540 mg) Medical Food Distributed by: N2 Health, La Quinta, CA. *2. AL Metabolic P Manufactured for Integrated Medical Center, Mesa AZ. *3. AstaMega-3 Balance Medical Food Distributed by: Lifestyle Research, Cheyenne, WY. *4.Body Balance H.E.M.M.L.A. Manufactured for: Health Masters, Auburndale, FL. *5. Cardio Protect Manufactured for: Shop The Care Group, LLC, Aurora, CO *6. Cardio-Krill Manufactured for: Whole Health Center, Lone Tree, CO. *7. CardiOmega Distributed by: Vail Valley Pharmacy, Edwards, CO. *8. CholeCare Manufactured for: Dr. Christina M. Tondora Scottsdale, AZ. *9. CHOLESTO-B… Recalling firm: Atlantic Pro Nutrients, Inc. dba XYMOGEN. Status: Terminated. FDA recall F-0815-2014.
- Adverse eventSource: openFDA
Adverse event report: International normalised ratio decreased, Weight fluctuation
Product: XYMOGEN CARNITEX; XYMOGEN PROSTATE FLO; XYMOGEN MELATONIN; XYMOGEN K2-45, K2 (AS MENIQUINONE-7 - 45MCG) PER CAPSULE. Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider. Reactions: International normalised ratio decreased, Weight fluctuation. FDA CAERS report 168513.
- Adverse eventSource: openFDA
Adverse event report: Cyanosis
Product: XYMOGEN GI PROTECT PEACH FLAVOR. Outcome: Other Serious or Important Medical Event, Visited a Health Care Provider. Reactions: Cyanosis. FDA CAERS report 166678.
- Adverse eventSource: openFDA
Adverse event report: Epistaxis, Influenza like illness, Pharyngitis
Product: XYMOGEN DIOVASC 500MG CAP. Outcome: Other Serious or Important Medical Event. Reactions: Epistaxis, Influenza like illness, Pharyngitis. FDA CAERS report 166677.
- Adverse eventSource: openFDA
Adverse event report: Abdominal pain upper, Alanine aminotransferase increased, Aspartate aminotransferase increased and 11 more
Product: XYMOGEN CINNDROMEX (LIVEWELL CENTER SUGAR SMART); XYMOGEN RESVERATIN PLUS (LIVEWELL CENTER CELLERATION); XYMOGEN OPTICLEANSE GHI VANILA DELIGHT (LIVEWELL CENTER DETOX ESSENTIALS VANILA DELIGHT); XYMOGEN OPTICLEANSE GHI CREAMY CHOCOLATE (LIVEWELL CENTER DETOX ESSENTIALS SHAKE CREAMY CHOCOLATE); XYMOGEN COQMAX UBIQUINOL (LIVEWELL CENTER Q RIGHT). Outcome: Hospitalization, Visited Emergency Room. Reactions: Abdominal pain upper, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood potassium decreased, Blood urea increased, Chest pain, Foreign body trauma, Hepatic enzyme increased, Influenza like illness, Lipase increased, Liver function test abnormal, Neutrophil count increased, Neutrophil percentage increased, White blood cell count increased. FDA CAERS report 166444.
- Adverse eventSource: openFDA
Adverse event report: Dyspnoea, Erythema, Pruritus
Product: XYMOGEN OPTIFIBER SCFA. Outcome: Other Serious or Important Medical Event, Visited Emergency Room. Reactions: Dyspnoea, Erythema, Pruritus. FDA CAERS report 146862.
Products
278 products listed for Xymogen.
Lab tests
Reviews
No reviews yet.